SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-066658
Filing Date
2018-11-07
Accepted
2018-11-07 16:12:50
Documents
41
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19038_110q.htm 10-Q 540900
2 EX-31.1 a18-19038_1ex31d1.htm EX-31.1 10903
3 EX-31.2 a18-19038_1ex31d2.htm EX-31.2 10876
4 EX-32.1 a18-19038_1ex32d1.htm EX-32.1 7179
11 GRAPHIC g190381bai001.jpg GRAPHIC 1977
  Complete submission text file 0001104659-18-066658.txt   2346208

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rarx-20180930.xml EX-101.INS 450958
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rarx-20180930.xsd EX-101.SCH 22379
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rarx-20180930_cal.xml EX-101.CAL 29794
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rarx-20180930_def.xml EX-101.DEF 54440
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rarx-20180930_lab.xml EX-101.LAB 202447
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rarx-20180930_pre.xml EX-101.PRE 133141
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37926 | Film No.: 181166477
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1